https://www.selleckchem.com/pr....oducts/itacitinib-in
0001) and mean total costs was significantly less in the SIPN group than in the VARD group (P = 0.008). Given the shorter hospitalization period, lower total cost and lower rate of reinterventions, SIPN may be superior to the step-up approach for patients with IPN than for those with VARD. Given the shorter hospitalization period, lower total cost and lower rate of reinterventions, SIPN may be superior to the step-up approach for patients with IPN than for those with VARD. To accelerate and improve multishot diffusion-weigh
Like
Comment
Share
